BioTelemetry, Inc. Reports Fourth Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
BioTelemetry (BEAT) Tops Q4 EPS by 1c
February 26, 2020 4:27 PM ESTBioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.48, $0.01 better than the analyst estimate of $0.47. Revenue for the quarter came in at $112 million versus the consensus estimate of $110.18 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:Our fourth quarter capped off a strong year for BioTelemetry, highlighted by our highest quarterly revenue and adjusted EBITDA in company history. These results came in... More
